Back
Advantest Vs. Novo Nordisk AS Industry Stock Comparison
Buy
61
ATEYY
Advantest
Last Price:
$60.13
Seasonality Move:
5.73%
Sell
9
NONOF
Novo Nordisk AS
Last Price:
$83.81
Seasonality Move:
8.64%
Sell
9
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $83.81. The Score for NONOF is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
ATEYY Stock Price Chart
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $83.81Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing selling pressure, which indicates risk of future bearish movement.
ATEYY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.22 | Buy |
Relative Strength Index (14 RSI): | 56.65 | Buy |
Chaikin Money Flow: | -23340 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.78 - 59.72) | Buy |
Bollinger Bands (100): | (45.59 - 59.31) | Buy |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.26 | Sell |
Relative Strength Index (14 RSI): | 29.14 | Sell |
Chaikin Money Flow: | -11150 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (88.64 - 110.9) | Sell |
Bollinger Bands (100): | (100.73 - 130.01) | Sell |
ATEYY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.14 | Buy |
20-day SMA: | 57.63 | Buy |
50-day SMA: | 58.38 | Buy |
200-day SMA: | 45.07 | Buy |
8-day EMA: | 58.31 | Buy |
20-day EMA: | 57.97 | Buy |
50-day EMA: | 56.71 | Buy |
200-day EMA: | 47.63 | Buy |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.44 | Sell |
20-day SMA: | 97.55 | Sell |
50-day SMA: | 103.66 | Sell |
200-day SMA: | 124.08 | Sell |
8-day EMA: | 87.79 | Sell |
20-day EMA: | 94.23 | Sell |
50-day EMA: | 102.94 | Sell |
200-day EMA: | 115.31 | Sell |
Advantest Earnings Growth & ATEYY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Advantest Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |